Detalhe da pesquisa
1.
The impact of coding germline variants on contralateral breast cancer risk and survival.
Am J Hum Genet
; 110(3): 475-486, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827971
2.
Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2.
J Med Genet
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609177
3.
Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400.
J Med Genet
; 61(4): 385-391, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123987
4.
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.
Lancet Oncol
; 25(1): 108-116, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070530
5.
Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancer.
J Med Genet
; 60(10): 974-979, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055167
6.
Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers.
J Med Genet
; 60(8): 740-746, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442995
7.
Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic.
Br J Cancer
; 128(9): 1690-1700, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841908
8.
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
Br J Cancer
; 128(11): 2063-2071, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005486
9.
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
Genet Med
; 25(9): 100846, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061873
10.
Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
J Med Genet
; 59(2): 133-140, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568438
11.
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer.
J Med Genet
; 59(2): 115-121, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758026
12.
Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester.
BMC Womens Health
; 23(1): 17, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635680
13.
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci.
Breast Cancer Res
; 24(1): 27, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35414113
14.
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
Int J Cancer
; 150(1): 73-79, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460111
15.
How do women who are informed that they are at increased risk of breast cancer appraise their risk? A systematic review of qualitative research.
Br J Cancer
; 127(11): 1916-1924, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002751
16.
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer.
Br J Cancer
; 126(8): 1157-1167, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34912072
17.
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
Genet Med
; 24(7): 1485-1494, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426792
18.
Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancer.
BMC Womens Health
; 22(1): 447, 2022 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371176
19.
Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial.
Br J Cancer
; 124(8): 1373-1378, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495601
20.
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Lancet
; 395(10218): 117-122, 2020 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839281